Treatment of Clostridioides difficile Infection
For C. difficile infection, oral vancomycin is the recommended first-line treatment for severe cases, while oral metronidazole can be used for mild to moderate cases, with fidaxomicin as an alternative for patients at high risk of recurrence. 1
Initial Assessment and Classification
Treatment should be based on disease severity:
- Non-severe CDI: <4 stools/day, no signs of severe colitis
- Severe CDI: Presence of any of these markers:
- WBC >15,000 cells/mm³
- Serum creatinine >1.5 times baseline
- Hypotension or shock
- Ileus or toxic megacolon
First-Line Treatment Algorithm
Non-severe CDI (Initial Episode)
- First choice: Metronidazole 500 mg orally three times daily for 10 days 1
- Alternative: Vancomycin 125 mg orally four times daily for 10 days 1
Severe CDI (Initial Episode)
- First choice: Vancomycin 125 mg orally four times daily for 10 days 1
- Alternative: Fidaxomicin 200 mg orally twice daily for 10 days 1, 2
Fulminant CDI (Severe with complications)
- Vancomycin 500 mg orally four times daily 1
- PLUS Metronidazole 500 mg intravenously every 8 hours 1
- Consider intracolonic vancomycin 500 mg in 100 mL saline as enema every 4-12 hours if ileus present 1
Management of Recurrent CDI
First Recurrence
- Treat as per initial episode based on severity 1
- If disease has progressed from non-severe to severe, use vancomycin 1
Second or Subsequent Recurrences
- Vancomycin 125 mg orally four times daily for at least 10 days 1
- Consider vancomycin taper/pulse strategy:
- Alternative: Fidaxomicin 200 mg twice daily for 10 days 1
- For multiple recurrences: Consider fecal microbiota transplantation (FMT) 1
Special Situations
When Oral Therapy Is Impossible
- Non-severe: Metronidazole 500 mg intravenously three times daily for 10 days 1
- Severe: Metronidazole 500 mg intravenously three times daily PLUS intracolonic vancomycin 500 mg in 100 mL saline every 4-12 hours and/or vancomycin 500 mg four times daily by nasogastric tube 1
Surgical Indications
Colectomy should be performed in:
- Perforation of the colon
- Systemic inflammation with deteriorating clinical condition not responding to antibiotics
- Toxic megacolon or severe ileus
- Consider surgery before serum lactate exceeds 5.0 mmol/L 1
Adjunctive Therapies
- Bezlotoxumab: Consider for patients at high risk for recurrence, especially immunocompromised patients or those with severe CDI 1
- Tigecycline: Consider only for patients who have failed standard treatments and have limited options 1
- Probiotics: Limited evidence supports their use as adjunctive treatment 1
Important Considerations
- Discontinue the inciting antibiotic as soon as possible 1
- Avoid antiperistaltic agents and opiates 1
- Provide supportive care including fluid resuscitation and electrolyte replacement 1
- For severe cases, consider albumin supplementation if hypoalbuminemia (<2 g/dL) is present 1
Common Pitfalls to Avoid
- Diagnostic errors: Only test symptomatic patients (≥3 unformed stools in 24 hours) as testing cannot distinguish between colonization and infection 1
- Inappropriate treatment selection: Using metronidazole for severe cases or multiple recurrences 1
- Delayed surgical consultation: Failure to involve surgeons early in fulminant cases 1
- Inadequate supportive care: Neglecting fluid resuscitation and electrolyte replacement 1
- "Test of cure": This is not recommended after CDI treatment 1
The treatment approach should be promptly initiated based on clinical presentation, with adjustments made as needed based on patient response and disease severity.